OVID THERAPEUTICS BOLDMEDICINE Trademark

Trademark Overview


On Wednesday, February 15, 2017, a trademark application was filed for OVID THERAPEUTICS BOLDMEDICINE with the United States Patent and Trademark Office. The USPTO has given the OVID THERAPEUTICS BOLDMEDICINE trademark a serial number of 87336954. The federal status of this trademark filing is REGISTERED as of Tuesday, December 4, 2018. This trademark is owned by Ovid Therapeutics Inc.. The OVID THERAPEUTICS BOLDMEDICINE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical product evaluation for the treatment of rare neurological diseases and disorders; Pharmaceutical products development for the treatment of rare neurological diseases and disorders; Pharmaceutical research and development for the treatment of rare neurological diseases and disorders
ovid therapeutics boldmedicine

General Information


Serial Number87336954
Word MarkOVID THERAPEUTICS BOLDMEDICINE
Filing DateWednesday, February 15, 2017
Status700 - REGISTERED
Status DateTuesday, December 4, 2018
Registration Number5619978
Registration DateTuesday, December 4, 2018
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 18, 2017

Trademark Statements


Description of MarkThe mark consists of the word "OVID" wherein the "I" in "OVID" is a stylized helix comprised of three diagonal curved lines, the word "THERAPEUTICS" located under "OVID" wherein "THERAPEUTICS" is smaller than "OVID" and is offset to the right under "OVID", a horizontal line located under "THERAPEUTICS" separating "OVID" and "THERAPEUTICS" from the word "BOLDMEDICINE" which is located under the horizontal line, wherein "BOLD" is highlighted as compared to "MEDICINE".
Pseudo MarkOVID THERAPEUTICS BOLD MEDICINE
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesPharmaceutical product evaluation for the treatment of rare neurological diseases and disorders; Pharmaceutical products development for the treatment of rare neurological diseases and disorders; Pharmaceutical research and development for the treatment of rare neurological diseases and disorders

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 22, 2017
Primary Code042
First Use Anywhere DateThursday, December 8, 2016
First Use In Commerce DateThursday, December 8, 2016

Trademark Owner History


Party NameOvid Therapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10036

Party NameOvid Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10036

Party NameOvid Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10036

Trademark Events


Event DateEvent Description
Monday, December 4, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 4, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, October 25, 2018TTAB RELEASE CASE TO TRADEMARKS
Thursday, October 25, 2018OPPOSITION TERMINATED NO. 999999
Thursday, October 25, 2018OPPOSITION DISMISSED NO. 999999
Thursday, September 7, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 7, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 25, 2017OPPOSITION INSTITUTED NO. 999999
Tuesday, July 25, 2017OPPOSITION PAPERS RECEIVED AT TTAB
Tuesday, July 18, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 18, 2017PUBLISHED FOR OPPOSITION
Wednesday, June 28, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 18, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 18, 2017EXAMINER'S AMENDMENT ENTERED
Thursday, May 18, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, May 18, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, May 18, 2017EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 17, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 17, 2017NON-FINAL ACTION E-MAILED
Wednesday, May 17, 2017NON-FINAL ACTION WRITTEN
Wednesday, May 10, 2017ASSIGNED TO EXAMINER
Thursday, February 23, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, February 22, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 18, 2017NEW APPLICATION ENTERED